Keynote: Patient-Centered Is a Promise. Patient-Driven Science Is an Operating Model

Session details:

What Changes When Patient Realities Shape the Asset—Not Just the Protocol

We have it backwards. By the time patients are asked for input, the decisions that matter have already been made. Shaping the protocol isn't the same as shaping the science, and patient realities should never follow strategy. They should drive it, from the very beginning.

In this keynote, Dr. Tania Small—physician, scientist and global biopharma leader—will make the case for patient-driven science as an enterprise operating model:

• Starting with patient realities—the biology, disease burden, unmet need and outcomes that matter most to patients and families living with the disease.

• Building evidence earlier to close care gaps, expand pipeline value and maximize patient impact through earlier signal-seeking—at dose expansion and Phase II.

• Earning trust through scientific rigor and real partnerships because there are no substitutes for credibility and you can’t manufacture scientific exchange. 

• Designing for implementation, not just approval, so patients actually receive what science is making possible.

Attendees won't just leave understanding patient-driven science. They'll leave knowing how to build and implement it—and with a new standard to measure it against: not whether patients were consulted, but whether patient realities truly changed decision making.